Study on the impact of lanthanum carbonate on FGF23 in chronic kidney disease

Phase 4

• Conditions: Chronic Kidney Disease

• Registration Number: JPRN-UMIN000015188
• Lead Sponsor: Daiko-Sunadabashi Clinic

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-10-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Not provided

Exclusion Criteria

Under 20 years old when informed concent Patients who have a contraindication that is shown in the product documents of lanthanum carbonate or calcium carbonate. Pregnant women or women with possibility of pregnancy. Patients who are inadequate by determination of physician in charge

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Comparison of FGF23 levels between Moderate protein-restricted diet with lanthanum carbonate versus moderate protein-restricted diet alone

Secondary Outcome Measures

Name	Time	Method
Comparison of serum levels of phosphate, Urinary phosphate excretion, Urinary protein content,eGFR,1/Cr,Cr,and Urinary FGF23 between Moderate protein-restricted diet with lanthanum carbonate versus moderate protein-restricted diet alone